Ken Griffin Enzo Biochem Inc Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$1.04 - $1.18 $32,968 - $37,406	-31,700 Reduced 93.24%	2,300 $2,000
Q2 2024 Aug 14, 2024	BUY	$1.04 - $1.28 $35,360 - $43,520	34,000 New	34,000 $37,000
Q3 2023 Nov 14, 2023	SELL	$1.3 - $1.87 $2,730 - $3,927	-2,100 Reduced 4.86%	41,100 $57,000
Q2 2023 Aug 14, 2023	SELL	$1.84 - $2.66 $6,624 - $9,576	-3,600 Reduced 7.69%	43,200 $79,000
Q1 2023 May 15, 2023	BUY	$1.0 - $2.51 $21,200 - $53,211	21,200 Added 82.81%	46,800 $113,000
Q4 2022 Feb 14, 2023	BUY	$1.16 - $2.42 $16,472 - $34,364	14,200 Added 124.56%	25,600 $36,000
Q3 2022 Nov 14, 2022	BUY	$2.1 - $2.73 $23,940 - $31,122	11,400 New	11,400 $25,000

15.5M

2.3K

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $48.7M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.